Suppr超能文献

通过高通量靶向DNA甲基化测序探索隐源性肝细胞癌中改变的DNA甲基化谱:隐源性肝细胞癌的初步研究

Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma.

作者信息

Wang Xin, Cheng Ya, Yan Liang-Liang, An Ran, Wang Xing-Yu, Wang Heng-Yi

机构信息

Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, People's Republic of China.

Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, People's Republic of China.

出版信息

Onco Targets Ther. 2020 Oct 6;13:9901-9916. doi: 10.2147/OTT.S267812. eCollection 2020.

Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) includes cryptogenic hepatocellular carcinomas (CR-HCC) that lack a defined cause. Specific DNA methylation patterns and comparisons of the aberrant alterations in DNA methylation between CR-HCC and adjacent peritumor tissues (APTs) have not yet been reported.

METHODS

The SureSelectXT Methyl-Seq Target Enrichment System was used to sequence targeted DNA methylation in three paired CR-HCC tissues and APTs. Gene Ontology (GO) enrichment and KEGG pathway analysis were performed to investigate the DNA methylation mechanism of CR-HCC. The mRNA expression levels of HOXB-AS3, HOXB6, HOXB3, USP18, MAP3K6, TIRAP, TNNI2, SHC3, CTTN, and TFAP2A, selected from the identified signaling pathways, were evaluated by quantitative real-time PCR (qPCR).

RESULTS

A total of 1728 differentially methylated regions (DMRs) were identified in tumor tissues compared with non-tumor tissues, of which 868 DMRs were hypermethylated and 860 were hypomethylated. The DMRs were mapped within 2091 DMR-associated genes (DMGs). The mRNA expression of HOXB-AS3, HOXB3, and MAP3K6 was downregulated in CR-HCC tissues compared to the APTs. However, the mRNA expression of TIRAP, SHC3, and CTTN was upregulated in the CR-HCC tissues. Differences between the mRNA expression of HOXB6, USP18, TNNI2, and TFAP2A in the CR-HCC and APTS tissues were not statistically significant. GO analysis showed that the molecular functions of "binding", "protein binding", and "cytoskeletal protein binding" were the main categories for the hypermethylated DMGs. The hypomethylated DMGs were mostly enriched in the molecular functions "binding", "protein binding", "calcium ion binding", among others. KEGG pathway analysis showed that the hypermethylated DMGs were enriched in several pathways such as "estrogen signaling pathway", while hypomethylated DMGs were enriched in several pathways such as "proteoglycans in cancer", suggesting that epigenetic modifications play important roles in the cryptogenic hepatocarcinogenesis.

CONCLUSION

These results provide useful information for future work to characterize the functions of epigenetic mechanisms on CR-HCC.

摘要

背景

肝细胞癌(HCC)包括病因不明的隐源性肝细胞癌(CR-HCC)。尚未报道CR-HCC与相邻瘤周组织(APT)之间特定的DNA甲基化模式以及DNA甲基化异常改变的比较。

方法

使用SureSelectXT甲基化测序靶向富集系统对三对CR-HCC组织和APT进行靶向DNA甲基化测序。进行基因本体论(GO)富集和KEGG通路分析以研究CR-HCC的DNA甲基化机制。通过定量实时PCR(qPCR)评估从鉴定出的信号通路中选择的HOXB-AS3、HOXB6、HOXB3、USP18、MAP3K6、TIRAP、TNNI2、SHC3、CTTN和TFAP2A的mRNA表达水平。

结果

与非肿瘤组织相比,在肿瘤组织中总共鉴定出1728个差异甲基化区域(DMR),其中868个DMR发生高甲基化,860个发生低甲基化。这些DMR定位在2091个DMR相关基因(DMG)内。与APT相比,CR-HCC组织中HOXB-AS3、HOXB3和MAP3K6的mRNA表达下调。然而,CR-HCC组织中TIRAP、SHC3和CTTN的mRNA表达上调。CR-HCC和APTS组织中HOXB6、USP18、TNNI2和TFAP2A的mRNA表达差异无统计学意义。GO分析表明,“结合”、“蛋白质结合”和“细胞骨架蛋白结合”的分子功能是高甲基化DMG的主要类别。低甲基化DMG大多富集在“结合”、“蛋白质结合”、“钙离子结合”等分子功能中。KEGG通路分析表明,高甲基化DMG富集在“雌激素信号通路”等多种通路中,而低甲基化DMG富集在“癌症中的蛋白聚糖”等多种通路中,表明表观遗传修饰在隐源性肝癌发生中起重要作用。

结论

这些结果为未来表征表观遗传机制对CR-HCC功能的研究提供了有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d9d/7547808/f067f24f4529/OTT-13-9901-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验